Anyone else looking for a partnership, page-6

March 2022 study done in France less positive.

"Aubreville et al. used Cellvizio system, which has a higher image refreshing frequency (1.2 vs 8 Hz) than Optiscan, which could limit artifacts [60]. "

With the conclusions:

More than 20 years after their introduction, CLE and EVCM are not yet used in routine clinical practice. Despite their potential clinical utility, technical limitations and difficulties in image interpretation remain. Automated reading of confocal microscopy images may revolutionize this technology and render it efficient and cost-effective."

Hopefully that is what the current studies Optiscan is focussing on.... To automate the process.